Oregon Administrative Rules
Chapter 836 - DEPARTMENT OF CONSUMER AND BUSINESS SERVICES, INSURANCE REGULATION
Division 200 - DEPARTMENT REGULATORY PROGRAMS
Section 836-200-0605 - Definitions
Current through Register Vol. 63, No. 9, September 1, 2024
For the purposes of OAR 836-200-0600 to 836-200-0670 the following definitions apply, unless the context requires otherwise:
(1) The "department" means the Oregon Department of Consumer and Business Services.
(2) "Pharmaceutical product" means a medication approved for human use by the federal Food and Drug Administration that may be legally dispensed only with a valid prescription from a health care provider.
(3) "Pharmaceutical representative" means a person that markets or promotes pharmaceutical products to health care providers.
(4) "License" means a license issued to a pharmaceutical representative by the department pursuant to OAR 836-200-0600 to 836-200-0670.
(5) "Licensee" means a person that holds a valid and unexpired license issued under this section.
(6) "Calendar year" means each successive period of 12 calendar months commencing on January 1 and ending on December 31.
(7) "Material change in a licensee's business operations" means any change in the following information:
(8) "Monetary value," for the purposes of describing the value of drug samples for reports made pursuant to OAR 836-200-0620(3)(e), means the monetary value of an equivalent volume or quantity of the prescription drug estimated using the WAC price for the most comparable NDC.
(9) "In writing" means through NIPR as allowed or by electronic mail.
(10) "Gift" means anything of economic value given to, or for the personal benefit of, a health care provider without consideration of equivalent or market value.
Statutory/Other Authority: ORS 731.244 & Or Laws 2021, ch 593
Statutes/Other Implemented: Or Laws 2021, ch 593